Tag Archives: Open Data

Why 23andMe Is About More Than You And Me 4

by • Clinical Trials, Data Management, LCOI • Tags: , , , ,

Advances in computational science and biology enable us to understand ourselves in ways that we could not just a few years ago.  Co-founded in 2006 by Anne Wojcicki, wife of Google co-founder Sergey Brin, 23andMe has emerged in the digital age to provide a view of our personal genetics - all for less than $100!

23andMe is evidence of Moore’s Law at work, and, in addition to giving unprecedented insight into our personal genome, efforts like 23andMe have innovative potential to change the way drugs are found and developed.

Thanks to Moore’s law, the cost per Human Genome is falling rapidly. More…

We Like Reply

by • LCOI, Open Innovation • Tags: , , , , ,

Datamob –  Public Data Put to Good Use

Datamob currently lists 227 data sources, 165 apps and 66 resources, which are categorized by 67 tags. It’s sort of like this:[/caption]

Datamob aims to show, in a very simple way, how public data sources can be used. We believe good things happen when governments and public institutions make data available in developer-friendly formats. Things that can help save us from bad government and bad decisions. We’re out to find the good things, and get developers excited about the data.

Device Helps Children with Disabilities Access Tablets

More…

We Like Reply

by • LCOI, Open Innovation • Tags: , , , , , , ,

Automated drug design using synthetic DNA self-assembly

Using a simple “drag-and-drop” computer interface and DNA self-assembly techniques, Parabon NanoLabs researchers have developed a new automated method of drug development that could reduce the time required to create and test medications, with the support of an NSF Technology Enhancement for Commercial Partnerships grant.

New Flu Forecasting Model Uses Google Search Data

More…

We Like Reply

by • LCOI, Open Innovation • Tags: , , , , , , , , ,

Innovation and Data – Jeffrey Hammerbacher

Heart Gadgets Test Privacy-Law Limits

A recent swell of digital-medical data collected on devices outside of a doctor’s office is raising some thorny questions: Who owns the rights to a patient’s digital footprint and who should control that information? WSJ’s Linda Blake reports.

From virus to viral: Researchers explore social media as preventative method for infectious diseases

MANHATTAN — When it comes to stopping illness, social media posts and tweets may be just what the doctor ordered. More…